Cathy Foley to lead expert methane reporting panel The federal government has appointed Chief Scientist Cathy Foley to lead an expert panel as part of...

Critical minerals prospectus showcases 55 projects The federal government has launched a new digital Australian Critical Minerals Prospectus,...

McKenzie’s Foods innovates in food products Australian owned baking and cooking manufacturer McKenzie’s Foods has partnered with packaging and...

Bisalloy’s profit growth flat Wear resistant and armoured steel manufacturer Bisalloy Steel Group sales tonnes were impacted in FY24 in Australia by...

Bisalloy’s profit growth flat Wear resistant and armoured steel manufacturer Bisalloy Steel Group sales tonnes were impacted in FY24 in Australia by...

Seatransport to design ships with closed cell foam Gold Coast based Ship design group Seatransport has secured the approval and exclusive licence for...

Fleet Space’s Centauri-6 satellite takes off flight at space discovery centre A new piece of next-generation Australian space technology is on...

The FDA accepts Axsome's resubmission of the NDA for AXS-07 for the acute treatment of migraine. A decision is due on Jan. 31, 2025. Shares rise.

News You Might Have Missed